The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells

Huilin Zhang1, Ping He2, Qing Zhou3,4

  • 1Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Abstract

Insights

CSN5 acts as an oncogene in cervical cancer, inhibiting cell proliferation and causing cell cycle arrest. Overexpression of CSN5 may predict resistance to MLN4924 (pevonedistat) treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • CSN5, a component of the Cop9 signalosome, is crucial for protein neddylation and implicated as an oncogene in various cancers.
  • The specific role of CSN5 in cervical cancer pathogenesis remained unexplored.

Purpose of the Study:

  • To investigate the expression profile and clinical significance of CSN5 in cervical cancer.
  • To elucidate the functional role of CSN5 in cervical cancer cell proliferation, cell cycle, and response to MLN4924.

Main Methods:

  • Analysis of TCGA and GEO datasets for CSN5 expression in cervical cancer.
  • CSN5 knockdown using CRISPR-Cas9 in Siha and Hela cell lines.
  • In vitro assays (CCK8, colony formation, 3D spheroid, cell cycle) and in vivo xenograft models.
  • Western blot analysis and MLN4924 treatment in CSN5-overexpressing cells.

Main Results:

  • Downregulation of CSN5 inhibited cervical cancer cell proliferation both in vitro and in vivo, with effects rescued by CSN5 re-expression.
  • CSN5 deletion induced cell cycle arrest but not apoptosis.
  • CSN5 overexpression conferred resistance to the anti-cancer effects of MLN4924 (pevonedistat).

Conclusions:

  • CSN5 functions as an oncogene in cervical cancer.
  • CSN5 may serve as a predictive biomarker for MLN4924 treatment efficacy in cervical cancer patients.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K